BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAMED - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAMED
X-ORIGINAL-URL:https://samed.org.za
X-WR-CALDESC:Events for SAMED
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20260707T100000
DTEND;TZID=Africa/Johannesburg:20260707T110000
DTSTAMP:20260625T223706
CREATED:20260611T120856Z
LAST-MODIFIED:20260611T120856Z
UID:16853-1783418400-1783422000@samed.org.za
SUMMARY:Code Forum: Legal Masterclass
DESCRIPTION:Could your pricing strategy\, rebate structure\, or customer incentives expose your business to competition law risk? \nAs competition authorities continue to scrutinise pricing practices across industries\, MedTech companies must ensure that their commercial strategies remain compliant while supporting growth\, innovation\, and market access. \nCompetition law remains one of the most important compliance considerations for MedTech companies operating in South Africa. Issues relating to excessive pricing\, incentives\, rebates\, and price discrimination can carry significant regulatory\, financial\, and reputational consequences if not properly understood and managed. \nThis practical masterclass presented by Bowmans will unpack the key principles governing these areas\, including recent developments and the application of the current Section 18 Exemption Framework. \nPresenters:\nHeather Irvine\, Partner\, Bowmans\nJulie Oppenheim\, Head: Pharmaceuticals and Healthcare Sector\, Bowmans \nThe session will explore: \n\nExcessive pricing and how it is assessed under competition law\nThe legal considerations surrounding incentives and rebate structures\nPrice discrimination and potential compliance risks\nThe purpose and practical implications of the current Section 18 exemption framework\nKey considerations for MedTech companies when developing commercial\, pricing\, and market access strategies\nPractical guidance to help organisations identify and mitigate competition law risks\n\nWhy Attend? \nWhether you are developing pricing strategies\, negotiating contracts\, engaging customers\, or supporting market access activities\, understanding competition law is essential to protecting your business and maintaining compliance. \nThis session will provide practical insights to help members: \n\nStrengthen compliance and governance practices\nBetter understand regulatory expectations\nAssess commercial arrangements and pricing models\nReduce legal and reputational risk\nNavigate the evolving healthcare regulatory environment with confidence\n\nWho Should Attend? \n\nExecutive Managers\nMarketing and Sales Managers\nRegulatory and Compliance Professionals\nMarket Access Specialists\nFinance Managers\n\nJoin us for this important legal masterclass and gain practical guidance from leading competition law experts on navigating complex commercial and regulatory considerations within the MedTech sector. \nRegister: Click Here
URL:https://samed.org.za/event/code-forum-legal-masterclass/
LOCATION:Virtual
CATEGORIES:Code,Compliance
ATTACH;FMTTYPE=image/png:https://samed.org.za/wp-content/uploads/2026/06/Graphic-lower-resolution-Teams-scaled.png
ORGANIZER;CN="SAMED":MAILTO:communication@samed.org.za
END:VEVENT
END:VCALENDAR